Versant Voyageurs I, L.P.
CIK 1745960 · last filed 2022-01-05
Versant Voyageurs I, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $48.0M of KDNY on Jan 5, 2022. Across all open-market trades the lifetime net is −$52.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.94M
2
5
-$52.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | 10%+ Owner | 5,486,220 | $40.39 | $221.59M | -$48.00M | 1 | 2022-01-05 |
| BDTX | 10%+ Owner | 5,225,482 | $1.71 | $8.94M | -$4.28M | 4 | 2020-12-16 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-05 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Sell (S) | −3,000,000 | -$48.00M | EDGAR |
| 2020-12-16 | BDTX | Other (J) | −83,136 | $0 | EDGAR |
| 2020-11-10 | BDTX | Sell (S) | −37,600 | -$1.24M | EDGAR |
| 2020-10-13 | BDTX | Sell (S) | −90,500 | -$3.03M | EDGAR |
| 2020-08-14 | BDTX | Other (J) | −1,200,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.